ruxolitinib 5 mg Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1/2 (1)

Interventional (1)

Chinese PLA General Hospital (1)

No (1)

No (1)

Adult (18+) (1)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadhematologic malignancy

I am/have/hadacute graft-versus-host disease

I am/have/hadacute graft versus host disease

I am/have/hadcell transplantation

I am/have/hadgraft versus host disease

I am/have/hadhematologic disorders

I am/have/hadblood disorder

I am/have/hadallogeneic hematopoietic stem cell transplant

I am/have/hadtumorigenicity

added new label for I am/have/had

more

I am looking for

I am looking formethylprednisolone

I am looking forruxolitinib

I am looking forregenerating islet derived protein 3

I am looking forruxolitinib 5 mg

I am looking forcorticosteroids

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For pediatric ages
Recruiting in 10s
Interventional Study
all
Recruiting

Low Dose Ruxolitinib in Combination With Methylprednisolone

This study is to determine the efficacy and safety of combined Low dose Ruxolitinib With Methylprednisone as Initial Therapy for the aGVHD(acute graft-versus-host disease )

cancer

hematologic malignancy

ruxolitinib

regenerating islet derived protein 3

acute graft-versus-host disease

0 views
19 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.